Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S. initial public offering on Thursday, at a time when it looks to tap into ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

Rock Health, a Silicon Valley venture-capital fund and research firm, for the first time released a list of digital-health startups that are likely candidates to go public in the next 12 months ...

MOUNTAIN VIEW, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the global leader in AI technology for coronary artery disease (CAD) management, today introduced its new brand identity ...

Heartflow was recently named one of Fast Company’s Most Innovative Companies in Medical Devices for 2025 and won the Innovation in Cardiac Imaging award at the Global Cardiovascular Awards 2025.

Heartflow just raised $35.8 million. Its diagnostic software reconfigures medical imaging data, particularly from CT scans, to build 3D models of patients' coronary arteries for physicians to use.

Circle’s successful IPO comes three years after Circle’s previous attempt at going public. The stablecoin issuer had plans to combine with a SPAC in 2022 at a $9 billion valuation.

In the DECIDE Registry, Heartflow’s AI-enabled Plaque Analysis led to medical management change in over half of patients beyond coronary computed tomography angiography (CCTA) alone. Full ...

The proceeds—marking the company’s second nine-figure fundraising—aim to help HeartFlow capitalize on its recent achievements, including an FDA clearance late last year for artificial ...

Plaque Analysis is a major function of the HeartFlow portfolio, which offers the only comprehensive, AI-driven, precision coronary care solution based on the guideline-directed cardiac CT pathway ...